3D printing-based drug-loaded implanted prosthesis to prevent breast cancer recurrence post-conserving surgery
3D printing-based drug-loaded implanted prosthesis to prevent breast cancer recurrence post-conserving surgery作者机构:Department of Pharmaceutical SciencesBeijing Institute of Radiation MedicineBeijing 100850China Weifang Medical UniversityWeifang 261000China Shandong University of Traditional Chinese MedicineJinan 250355China Anhui Medical UniversityHefei 230032China
出 版 物:《Asian Journal of Pharmaceutical Sciences》 (亚洲药物制剂科学(英文))
年 卷 期:2021年第16卷第1期
页 面:86-96页
核心收录:
学科分类:100702[医学-药剂学] 1007[医学-药学(可授医学、理学学位)] 1006[医学-中西医结合] 1002[医学-临床医学] 100602[医学-中西医结合临床] 10[医学]
基 金:the National Natural Science Foundation of China(No.81472951)for financial support of this work
主 题:Prosthesis Breast cancer Microspheres Paclitaxel Doxorubicin Metastasis
摘 要:Systemic chemotherapy of breast cancer is commonly delivered as a large dose and has toxic side *** chemotherapy would overcome the shortcomings of systemic reconstruction and could play an important role in breast cancer surgery according to personalized *** application of three-dimensional(3D)printing technology makes personalized customization *** designed and prepared a prosthesis containing paclitaxel(PTX)and doxorubicin(DOX)microspheres(PPDM)based on 3D printing to prevent tumor recurrence and metastasis after breast conserving *** has good biocompatibility and was used as a drug carrier in this *** average particle size of the PTX and DOX microspheres were approximately 3.1μm and 2.2μm,*** drug loading of PTX and DOX microspheres was 4.2% and 2.1%,*** vitro drug release studies demonstrated that the 3D-printed prosthesis loaded with PTX and DOXmicrospheres could release the drugs continuously for more than 3 weeks and thereby suppress cancer recurrence with reduced side *** PTX and DOX microspheres not only exerted a synergistic effect,but also achieved a good sustained release *** vivo evaluation showed that the PPDM could effectively inhibit breast cancer recurrence andmetastasis inmice with breast *** are expected to achieve postoperative chemotherapy for breast cancer and be highly efficient to prevent local breast cancer recurrence and metastasis.